Summary

Organization name

Profile

Wyeth improves the lives of millions of people around the world with its outstanding products. And new, innovative medicines are on the way. With research and development programs focused on small molecules, vaccines and biotechnology, Wyeth is exploring more than 60 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer's disease and schizophrenia.

With a diverse and global set of commercial franchises, development projects and research programs, Wyeth recognizes the critical strategic importance of developing and nurturing partnerships of many kinds. Such partnerships include compound or product licenses, research collaborations, technology and patent licenses, as well as other asset acquisitions or divestitures. Wyeth's efforts in small molecules, vaccines, and biopharmaceuticals are focused in these key therapeutic and disease areas of high unmet need:

Inflammatory Diseases

• Rheumatoid arthritis
• Osteoarthritis
• Psoriasis
• Asthma
• Chronic obstructive pulmonary disease

Oncology

• Breast cancer
• Lung cancer
• Prostate cancer
• Colon cancer
• Renal cell cancer
• Melanoma
• Mantle cell lymphoma
• Lymphomas

Their efforts in oncology include chemotherapy agents for acute myeloid leukemia and a platelet growth promoter to help patients after chemotherapy. Wyeth currently has several promising oncology therapies in clinical trials, including treatments for renal cell carcinoma, breast cancer and mantle cell lymphoma.

Women's Health and Bone Repair

• Osteoporosis
• Contraception
• Vasomotor symptoms of menopause
• Endometriosis
• Urinary incontinence
• Bone fracture
• Tendon repair
• Muscle repair

For more than 60 years, Wyeth has been the leader in women´s health care with its postmenopausal hormone therapies and oral contraceptives.

Wyeth is committed to developing new therapies with the potential to significantly improve the health of women worldwide. To achieve this goal, Wyeth formed the Women´s Health Research Institute® - the first institute in the pharmaceutical industry dedicated solely to research in women´s health. After several years of research, Wyeth introduced new low doses of its postmenopausal hormone therapy products. Research currently is underway on several other products intended to improve the quality of women´s lives.

Wyeth´s musculoskeletal disorders franchise develops important new therapies for patients with joint and bone disease. Their products include treatments for rheumatoid arthritis that help patients lead more active lives. In addition, Wyeth has a strong presence in the osteoarthritis treatment market. In research, Wyeth scientists are investigating novel treatments for bone and tissue repair.

Cardiovascular and Metabolic Disorders

• Atherosclerosis
• Thrombosis
• Lipid management
• Diabetes Obesity/"diabesity"
• Metabolic syndrome
• Muscular dystrophy

Their broad and expanding internal medicine franchise includes cardiovascular and gastrointestinal products. Wyeth´s internal medicine researchers are exploring novel approaches to treat diabetes, heart conditions and vascular disorders.

Neuroscience

• Alzheimer's disease
• Depression and anxiety
• Schizophrenia and bipolar disorder
• Multiple sclerosis
• Neurodegeneration
• Pain
• Stroke

Wyeth´s global neuroscience efforts have produced a novel therapy for depression and for the treatment of generalized anxiety disorder. Working with three discovery platforms - small molecules, vaccines and biotechnology - Wyeth researchers continue to develop treatments targeted for a wide range of central nervous system disabilities, such as multiple sclerosis, Alzheimer's disease, depression, anxiety and schizophrenia.

Wyeth's Consumer Division

They are seeking novel, proprietary drug delivery technologies for OTC or Rx.

Wyeth is primarily interested in in-licensing late-stage (early Phase II or later) development projects or marketed products on a worldwide basis.

Their core therapeutic areas are:

• Analgesics (oral/topical/transdermal)
• Respiratory (cough/cold/allergy/sinus)
• Nutritionals (vitamin and mineral supplements)
• Gastrointestinals/topicals

Other areas of interest include OTC or Rx drugs with OTC switch potential for a variety of indications, as well as nutritional or drug solutions for problems associated with aging (eg, sleep disorders and eye and heart health).

Contact Information is provided online.

URL

Your feedback

back